DeepMatter Group PLC Business Update and Financing (0987W)
18 December 2021 - 3:59AM
UK Regulatory
TIDMDMTR
RNS Number : 0987W
DeepMatter Group PLC
17 December 2021
17 December 2021
DeepMatter Group Plc
Business update and financing
DeepMatter Group Plc (AIM: DMTR, "DeepMatter", the "Group"), the
international digital chemistry data company, today provides a
business update and details on discussions in relation to equity
financing.
Business update
The Group's interim results published on 22 September 2021,
highlighted the increase in commercial traction with active users
up 48 per cent and customers up to 40. It stated that DeepMatter is
also working with five of the 10 largest pharmaceutical companies.
Revenue increased to GBP0.7m and the Group saw a strengthened sales
pipeline and continued growth in users and trials. As at 30 June
2021, DeepMatter had cash of GBP1.8m.
DeepMatter is now in advanced discussions to provide its
DigitalGlassware(R) platform and data to Standigm Inc., a leading
workflow artificial intelligence (AI) drug discovery company, based
in South Korea with an increasing international footprint. Based on
current discussions, the agreement is expected to generate mid
six-figure revenue in the first 12 months. The Group expects to
finalise the agreement over the coming weeks.
Financing discussions
The Group currently has cash of GBP0.4m, ahead of its biggest
billing periods in Q1. However, the Directors concluded in Q4 2021
that the Group required further cash resources in order to execute
on its strategy of customer acquisition and investing in revenue
growth.
The Directors believe that it is critical for the long-term
potential of the business to raise enough funds in order to invest
significantly, capture market share and grow revenues. Without
further cash resources, the Group would have to re-evaluate its
strategy and outlook.
The Directors have engaged with existing and potential
institutional investors over the past six weeks. However, there has
been no conclusion as yet reached in relation to the amount of
funds that can be raised or the pricing of any new equity issued.
The Group believes it may be possible to secure a material equity
investment, but that this would likely be at a significant discount
to the current share price.
Shareholders should be aware that discussions remain ongoing
with the Directors currently believing any equity funding will
complete in Q1 2022. An update will be made as and when
appropriate.
For more information, please contact:
DeepMatter Group Plc
Mark Warne, Chief Executive Officer 0141 548 8156
Canaccord Genuity Limited (Nominated Advisor and Broker) 020 7523 8000
Bobbie Hilliam
Meare Consulting 07990 858548
Adrian Duffield
About DeepMatter Group Plc
DeepMatter is building a unique, fully integrated digital
chemistry cloud platform of chemical reaction data for scientists,
who are working on early-stage chemical discovery &
development.
DeepMatter is integrating technology with chemistry to enable
scientists, principally in the commercial sector, to easily perform
and optimise chemistry. It is building, structuring and analysing
chemical reaction databases and using this substantial data for
real-time innovation and productivity gains in the chemical
industry - particularly pharmaceutical companies engaged in
pre-clinical drug discovery & development. This data is also
now enabling Artificial Intelligence (AI) driven chemical
automation.
Visit: www.deepmatter.io and follow @deepmattergroup
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TSTEAKAXFLXFFFA
(END) Dow Jones Newswires
December 17, 2021 11:59 ET (16:59 GMT)
Deepmatter (LSE:DMTR)
Historical Stock Chart
From Dec 2024 to Jan 2025
Deepmatter (LSE:DMTR)
Historical Stock Chart
From Jan 2024 to Jan 2025